Dibutyryl cyclic adenosine monophosphate restores the ability of aged Leydig cells to produce testosterone at the high levels characteristic of young cells

被引:35
作者
Chen, HL [1 ]
Liu, J [1 ]
Luo, L [1 ]
Zirkin, BR [1 ]
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Div Reprod Biol, Baltimore, MD 21205 USA
关键词
D O I
10.1210/en.2004-0639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The wealth of knowledge about the function and regulation of adult Leydig cells, the cells within the mammalian testis that produce testosterone, make these cells ideal for studying principles and mechanisms of aging. A hallmark of mammalian aging is decreased serum testosterone concentration. In the Brown Norway rat, this has been shown to be associated with the reduced ability of aged Leydig cells to produce testosterone in response to LH. Herein, we demonstrate that culturing the aged cells with dibutyryl cAMP, a membrane-permeable cAMP agonist that bypasses the LH receptor-adenlyly cyclase cascade, restores testosterone production to levels comparable to those of young cells and also restores steroidogenic acute regulatory protein and P450scc, the proteins involved in the rate-limiting steps of steroidogenesis. These results strongly suggest that signal transduction deficits are responsible for reduced steroidogenesis by aged Leydig cells and that bypassing signal transduction reverses the steroidogenic decline by the aged cells.
引用
收藏
页码:4441 / 4446
页数:6
相关论文
共 31 条
[21]  
PACIFICI RE, 1991, GERONTOLOGY, V37, P166
[22]   THE INHIBITORY GTP-BINDING PROTEIN (GI) OCCURS IN RAT LEYDIG-CELLS AND IS DIFFERENTIALLY MODIFIED BY LUTROPIN AND 12-O-TETRADECANOYLPHORBOL 13-ACETATE [J].
PLATTS, EA ;
SCHULSTER, D ;
COOKE, BA .
BIOCHEMICAL JOURNAL, 1988, 253 (03) :895-899
[23]  
SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1
[24]  
STRATTON LG, 1973, J REPROD FERTIL, V35, P235
[25]   Recent neuroendocrine facets of male reproductive aging [J].
Veldhuis, JD .
EXPERIMENTAL GERONTOLOGY, 2000, 35 (9-10) :1281-1308
[26]   Androgen replacement therapy in the aging male - A critical evaluation [J].
Vermeulen, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (06) :2380-2390
[27]   The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity [J].
Vlasova, II .
PLATELETS, 2000, 11 (07) :406-414
[28]  
Wang C, 2002, NOVART FDN SYMP, V242, P82
[29]   Editorial: Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause? [J].
Wang, C ;
Swerdloff, RS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1462-1466
[30]   RESTORATION EFFECTS OF EXOGENOUS LUTEINIZING-HORMONE ON THE TESTICULAR STEROIDOGENESIS AND LEYDIG-CELL ULTRASTRUCTURE [J].
WING, TY ;
EWING, LL ;
ZEGEYE, B ;
ZIRKIN, BR .
ENDOCRINOLOGY, 1985, 117 (05) :1779-1787